Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

NOUVELLE PHARMACIE DE LA PLACE : revenue, balance sheet and financial ratios

NOUVELLE PHARMACIE DE LA PLACE is a French company founded 2 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-AMAND-MONTROND (18200), this company of category PME shows in 2024 a net income positive of 61 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - NOUVELLE PHARMACIE DE LA PLACE (SIREN 981068901)
Indicator 2024
Revenue N/C
Net income 60 633 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2024, NOUVELLE PHARMACIE DE LA PLACE generates positive net income of 61 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

60 633 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 603%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 12%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

603.177%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

12.072%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

80.3%

Solvency indicators evolution
NOUVELLE PHARMACIE DE LA PLACE

Sector positioning

Debt ratio
603.18 2024
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average

In 2024, the debt ratio of NOUVELLE PHARMACIE DE LA ... (603.18) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
12.07% 2024
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch

In 2024, the financial autonomy of NOUVELLE PHARMACIE DE LA ... (12.1%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 148.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

148.001

Liquidity indicators evolution
NOUVELLE PHARMACIE DE LA PLACE

Sector positioning

Liquidity ratio
148.0 2024
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average

In 2024, the liquidity ratio of NOUVELLE PHARMACIE DE LA ... (148.00) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of NOUVELLE PHARMACIE DE LA PLACE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of NOUVELLE PHARMACIE DE LA PLACE is estimated at 846 481 € (range 589 476€ - 1 266 384€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
589k€ 846k€ 1266k€
846 481 € Range: 589 476€ - 1 266 384€
NAF 5 année 2024

Valuation method used

Net Income Multiple
60 633 € × 14.0x = 846 482 €
Range: 589 476€ - 1 266 385€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare NOUVELLE PHARMACIE DE LA PLACE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about NOUVELLE PHARMACIE DE LA PLACE

What is the revenue of NOUVELLE PHARMACIE DE LA PLACE ?

The revenue of NOUVELLE PHARMACIE DE LA PLACE is not publicly disclosed (confidential accounts filed with INPI).

Is NOUVELLE PHARMACIE DE LA PLACE profitable?

Yes, NOUVELLE PHARMACIE DE LA PLACE generated a net profit of 61 k€ in 2024.

Where is the headquarters of NOUVELLE PHARMACIE DE LA PLACE ?

The headquarters of NOUVELLE PHARMACIE DE LA PLACE is located in SAINT-AMAND-MONTROND (18200), in the department Cher.

Where to find the tax return of NOUVELLE PHARMACIE DE LA PLACE ?

The tax return of NOUVELLE PHARMACIE DE LA PLACE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does NOUVELLE PHARMACIE DE LA PLACE operate?

NOUVELLE PHARMACIE DE LA PLACE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.